ISMICS 15 ISMICS 15 ISMICS 15
Exhibitors & Sponsors
 
 
Past Meetings
Future Meetings

Back to 2015 Annual Meeting Posters


The use of Tissue Microarray Technology on recognition the Simultaneous EGFR and VEGF alterations in Non-Small Cell Lung Carcinoma.
Athanasios Stamatelopoulos1, TIMOTHEOS SAKELLARIDIS2, Evangellos Tsiambas3, Nikolaos Atzoulatos1, Petros Michos1, Ioannis Gakidis1, Christos Chatziantoniou1, Nikolaos Theakos1, Dimostenis Bouros4.
1KAT GENERAL HOSP OF ATHENS, ATHENS, Greece, 2Southampton Univ. Hospital, Southampton, United Kingdom, 3401 Gen. Military Hosp., ATHENS, Greece, 4Dimocrition Univer. Of Thrace, Med. Scool, Dep. of Resp. Deseas, Alexandroupoli, Greece.

OBJECTIVE: Epidermal growth factor receptor (EGFR) overexpression is observed in significant proportions of non-small cell lung carcinomas (NSCLC). Furthermore, overactivation of vascular endothelial growth factor (VEGF) leads to increased angiogenesis implicated as an important factor in vascularization of those tumors
METHODS: Using Ttissue Microarray Technology, forty-paraffin (n = 40) embedded, histologically confirmed primary NSCLCs were cored and re-embedded into a recipient block. Immunohistochemistry was performed for the determination of EGFR and VEGF protein levels which were evaluated by the performance of computerized image analysis. EGFR gene amplification was studied by chromogenic in situ hybridization based on the use of EGFR gene and chromosome 7 centromeric probes
RESULTS: EGFR overexpression was observed in 23/40 (57.5%) cases and was correlated to the stage of the tumors (p = 0.001), whereas VEGF was overexpressed in 35/40 (87.5%) cases and was correlated to the stage of the tumors (p = 0.005) and to the smoking history of the patients (p = 0.016). Statistical significance was assessed comparing the protein levels of EGFR and VEGF (p = 0.043, k = 0.846). EGFR gene amplification was identified in 2/40 (5%) cases demonstrating no association to its overall protein levels (p = 0.241), whereas chromosome 7 aneuploidy was detected in 7/40 (17.5%) cases correlating to smoking history of the patients (p = 0.013).
CONCLUSIONS: A significant subset of NSCLC is characterized by EGFR and VEGF simultaneous overexpression and maybe this is the eligible target group for the application of combined anti-EGFR/VEGF targeted therapies at the basis of genetic deregulation (especially gene amplification for EGFR).


Back to 2015 Annual Meeting Posters
© 2026 International Society for Minimally Invasive Cardiothoracic Surgery. All Rights Reserved. Read Privacy Policy.